Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Profound Medical Corp PROF


Primary Symbol: T.PRN

Healthcare Medical Devices
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed... see more

Recent & Breaking News (TSX:PRN)

Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13

GlobeNewswire September 21, 2023

Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference

GlobeNewswire September 19, 2023

Profound Medical Announces At-the-Market Offering of up to US$30,000,000

GlobeNewswire September 6, 2023

Profound Medical Announces Second Quarter 2023 Financial Results

GlobeNewswire August 9, 2023

Profound Medical to Release Second Quarter 2023 Financial Results on August 9 - Conference Call to Follow

GlobeNewswire August 2, 2023

Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases

GlobeNewswire June 2, 2023

Profound Medical Announces Upcoming Investor Events

GlobeNewswire May 30, 2023

Profound Medical to Participate in A.G.P.'s Virtual Healthcare Conference

GlobeNewswire May 18, 2023

Profound Medical Annual and Special Meeting of Shareholders Voting Results

GlobeNewswire May 17, 2023

Profound Medical Announces First Quarter 2023 Financial Results

GlobeNewswire May 10, 2023

TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting

GlobeNewswire May 1, 2023

Profound Medical to Release First Quarter 2023 Financial Results on May 10 - Conference Call to Follow

GlobeNewswire April 19, 2023

Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire April 19, 2023

Profound Medical Announces Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire March 7, 2023

Profound Medical to Present at the 43rd Annual Cowen Health Care Conference

GlobeNewswire March 1, 2023

Profound Medical to Release Fourth Quarter and Full Year 2022 Financial Results on March 7 - Conference Call to Follow

GlobeNewswire February 14, 2023

Profound Medical to Present at the 2022 Jefferies London Healthcare Conference

GlobeNewswire November 8, 2022

Profound Medical Announces Third Quarter 2022 Financial Results

GlobeNewswire November 3, 2022

Profound Medical to Release Third Quarter 2022 Financial Results on November 3 - Conference Call to Follow

GlobeNewswire October 13, 2022

Profound Medical (TSX:PRN) confirms positive trends after four years with TULSA-PRO

Brieanna McCutcheon  September 26, 2022